Jan 18, 2022 / 09:30PM GMT
Operator
Good day, and welcome to today's conference call to discuss Oncocyte's announcement of an agreement with Thermo Fisher Scientific. (Operator Instructions) Please note this conference is being recorded.
At this time, I would like to turn the call over to Bob Yedid of LifeSci Advisors. Please go ahead.
Robert A. Yedid - LifeSci Advisors, LLC - MD
Thank you, Shamali. Good day, and welcome to today's Oncocyte's call to discuss the announcement of a development and co-marketing agreement with Thermo Fisher Scientific to expand access to precision oncology. If you have not seen today's press release, please visit the company's website on the Investors page.
Before turning the call over to Ronnie Andrews, Oncocyte's President and Chief Executive Officer, I would like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical facts are forward-looking statements. We encourage you to review the company's SEC filings, including, without
OncoCyte Corp to Discuss Development and Co-Marketing Agreement with Thermo Fisher Scientific Inc Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot